Osa EO - Search Results

1

Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla.

Ge Y, Zohrabian VM, Osa EO, Xu J, Jaggi H, Herbert J, Haacke EM, Grossman RI. Ge Y, et al. Among authors: osa eo. J Magn Reson Imaging. 2009 May;29(5):1190-4. doi: 10.1002/jmri.21758. J Magn Reson Imaging. 2009. PMID: 19388109 Free PMC article.

2

Dose to craniofacial region through portal imaging of pediatric brain tumors.

Hitchen CJ, Osa EO, Dewyngaert JK, Chang J, Narayana A. Hitchen CJ, et al. Among authors: osa eo. J Appl Clin Med Phys. 2012 Jan 5;13(1):3385. doi: 10.1120/jacmp.v13i1.3385. J Appl Clin Med Phys. 2012. PMID: 22231206 Free PMC article.

3

Prone breast intensity modulated radiation therapy: 5-year results.

Osa EO, DeWyngaert K, Roses D, Speyer J, Guth A, Axelrod D, Fenton Kerimian M, Goldberg JD, Formenti SC. Osa EO, et al. Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):899-906. doi: 10.1016/j.ijrobp.2014.03.036. Epub 2014 May 24. Int J Radiat Oncol Biol Phys. 2014. PMID: 24867535 Free PMC article. Clinical Trial.

4

Primary therapy in breast cancer: what have we learned from landmark trials?

Bozza C, Osa EO, Puglisi F. Bozza C, et al. Among authors: osa eo. Womens Health (Lond). 2013 Nov;9(6):583-93. doi: 10.2217/whe.13.55. Womens Health (Lond). 2013. PMID: 24161310 Free article. Review.

5

Making capecitabine targeted therapy for breast cancer: which is the role of thymidine phosphorylase?

Bonotto M, Bozza C, Di Loreto C, Osa EO, Poletto E, Puglisi F. Bonotto M, et al. Among authors: osa eo. Clin Breast Cancer. 2013 Jun;13(3):167-72. doi: 10.1016/j.clbc.2012.10.002. Epub 2012 Dec 5. Clin Breast Cancer. 2013. PMID: 23218471 Review.

6

Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients.

Bozza C, Puglisi F, Lambertini M, Osa EO, Manno M, Del Mastro L. Bozza C, et al. Among authors: osa eo. Endocr Relat Cancer. 2014 Jan 21;21(1):R51-65. doi: 10.1530/ERC-13-0335. Print 2014 Feb. Endocr Relat Cancer. 2014. PMID: 24292601 Review.

7

Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a-b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery.

Henschke CI, Yip R, Sun Q, Li P, Kaufman A, Samstein R, Connery C, Kohman L, Lee P, Tannous H, Yankelevitz DF, Taioli E, Rosenzweig K, Flores RM; I-ELCAP; IELCART Investigators. Henschke CI, et al. J Thorac Oncol. 2024 Mar;19(3):476-490. doi: 10.1016/j.jtho.2023.10.002. Epub 2023 Oct 6. J Thorac Oncol. 2024. PMID: 37806384

8

Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.

Devadas K, Boykins RA, Hardegen NJ, Philp D, Kleinman HK, Osa EO, Wang J, Clouse KA, Wahl LM, Hewlett IK, Rappaport J, Yamada KM, Dhawan S. Devadas K, et al. Among authors: osa eo. Peptides. 2006 Apr;27(4):611-21. doi: 10.1016/j.peptides.2005.09.013. Epub 2005 Oct 26. Peptides. 2006. PMID: 16256245

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page